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ABSTRACT 
The main message we are trying to get across throughout the article is that the placebo is not an inert entity 
but instead it has a potential of subjective interpretation, a healing potential of its own, over and above that 
of any healing potential of the medication per se. Such healing potential is greatly dependent on how 
strong the interpretation value in being healed is that is created by the doctor. In this regard, we are also 
arguing that there are myriads possibilities at work that can influence how strong this interpretation value 
can become. The crucial role of contemporary medicine should be to expand the use of these interpretation 
effects even more and use them to help reduce any negative mental states that could continue to suppress 
the immune system after the initial healing. In other words, medicine should use the power of interpretation 
effect not only to re-arouse the immune system temporarily but permanently. In order to achieve a complete 
process of permanent healing it is necessary to take advantage of making full use of the powerful interpretation 
value through psychosocial context. It is possible to do that beyond the usual “sugar pill” through evidence 
based approach – a science of compassionate care! By introducing the new operational placebo definitions, 
we clearly show that the human mind (unconscious and conscious) is an inevitable substance involved in 
the Healing Process. The terms “placebo”, “placebo effect”, and “placebo response” are re-defined into the new 
working definitions. We explain how there is no more distinction (duality) such as body / mind, specific / 
nonspecific or health / disease, which offers new insights for future directions in contemporary Neuroethics. 
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INTRODUCTION 
More than 50 years ago a revolutionary book titled “Introduction to a Submolecular Biology” 
announced the crucial importance of quantum physics in biological systems [1]. Less than 
fifteen years later research in biophysics showed that electromagnetic frequencies as 
energetic signaling mechanisms are one hundred times more efficient and incredibly faster in 
transmitting information from the environment compared to the chemical signals such as 
hormones or neurotransmitters [2]. Energies like microwaves, radio frequencies, extremely 
low frequencies, sound frequencies, and scalar energy have shown to have a significant 
influence on each aspect of biological regulation. Indeed discovery that quantum physics but 
not Newtonian laws regulate molecule movements, which in addition generate life has 
offered further support of previous findings [3]. 
Despite the fact that many of pioneering scientific reports in the past sixty years have 
revealed the importance of those “invisible” forces of electromagnetic spectrum and were 
even published in peer reviews, these finding were somehow neglected [4-11]. Many 
professional and locally produced devices have been constructed for research purposes in 
order to manipulate experimental conditions by exposing the living organisms to different 
ranges and frequencies of electromagnetic fields [12]. In one experimental study, the 
germination and growth of Lemma Minor by exposure to square pulse and 16 Hz sinusoidal 
magnetic fields revealed statistically significant differences [13]. 
Back to the very beginning of the humankind, it is not that hard to understand that culture is 
deeply embedded into human biology because of perceptual and attentional processes [14, 15]. 
Speaking about old primitive societies, they had long healing ceremonies and very complex 
rituals that sometimes lasted even more than a week [14]. Such meaningful healing strategies 
in primitive cultures were extremely impressive and respected for they were capable to 
induce powerful psychological (symbolic) component of the healing process, nowadays 
known as psychosocial context or meaning response [15]. Rituals might trigger subjective 
expectations of different emotional states: joy, anxiety, relaxation, altered states of 
consciousness through biased attention. Attentional biases can influence what information 
people prefer to focus upon. Indeed subjects with chronic pain and emotional problems show 
increased attention to information regarding their concerns [16, 17]. This bias in attention 
accompanied by emotional states and perceived from the cognitive perspective corresponds to 
hypervigilance [18]. Cognitive self-evaluation about amount of reported failures in memory 
and attentional domains is a good predictor of vigilance performance in complex tasks [19]. 
Anxiety modulates attention [20], in particular trait anxiety modulates top down, executive 
control network [21] while, state anxiety is more responsible for bottom up, alerting/orienting 
attentional networks [22]. Furthermore, in a computer-based neurocognitive test using the 
ANTI-V paradigm individual differences in vigilance performance were measured. A 
step-wise multiple regression analysis showed that vigilance performance (Signal Detection 
Theory – SDT indices of Vigilance), were predicted by cognitive and somatic state anxiety, 
but not trait anxiety [23]. Under negative psychological states usually present in subjects with 
health problems, it is obvious that their hyper-vigilant attentional focus depends on the level 
of concerns in how to get well again. In this regard, psychosocial context through a 
compassionate care can become an important healing determinant.  
Contemporary medicine (evidence-based) has on the other hand developed scientific methods 
and highly sophisticated technology, which enables it to be more successful in the 
pharmacological and physiological component of the healing process. In his doctoral 
dissertation, Getz highlights an interesting topic that fits well with the concerns of Heidegger N. Gorjup and R. Gorjup 
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and Foucault about the sophisticated technology. He says: “Can it be that professionals as well 
as lay people are currently becoming increasingly distracted and desensitized, as a result of 
medical technology’s particular way of enframing the human condition, in such a way that we 
lose sight of the essence of what it means to be human, in sickness and in health?” [24; p.113]. 
For our discussion, it is important that the placebo/nocebo response is an integral component 
of every treatment, and can not be avoided in even the most modern, sophisticated evidence-
based medical treatment. Both the modern medicine and the primitive treatments of our 
ancestors share the same integral component of the healing process: the “nonspecific” 
component of the treatment. If we accept that, the history of medicine was more or less the 
history of the placebo response [25] than we can assume that the modern medical treatment 
has evolved from the placebo treatment, or to put another way, the “specific” factors have 
evolved from the “nonspecific” ones. Furthermore, if the primitive - nonscientific healing of 
our ancestors had been so useless, or if “nonspecific” factors had not played an integral role 
in the healing process throughout history, it is very likely that humankind would not have 
survived those harmful “nocebo” treatments, and thus there would have been no modern 
evidence-based medicine [26, 27]. Taking into account above arguments, we can hypothesize 
that what we perceive and to what we narrow our focus of attention on, becomes important, 
meaningful and makes sense for our further understanding and interpretation. 
In the present article we intentionally bypass the extensive overview of the Placebo literature. 
Instead, we introduce the brief history of Placebo definitions to better understand their 
metamorphosis and point out some contemporary concepts of this puzzling phenomena. In 
addition we re-define Placebo terms and propose three major premises as the future standards 
for Contemporary Neuroethics. In conclusions we discuss that the placebo phenomena is very 
real and natural, and that there is nothing supernatural in its process. 
METAMORPHOSIS OF HISTORICAL PLACEBO DEFINITIONS 
In Table 1 one can see how the term Placebo has changed from the late 18
th century until the 
beginning of the third millennium [28]. 
It is important to note, that the definition from the 1785 was misquoted [25] and instead of “a 
common place method of medicine” the actual definition was “a common place method or 
medicine”. So the early definitions classify as placebo not only medicines or active drugs, but 
also other non-drug treatments and methods such as magic, psychotherapy, hypnosis ... 
Early definitions did not define placebo as an inert substance until about 1950, when the double 
Table 1. (Continued on p.337) Some dictionary definitions of Placebo. 
Source  Year  Definition of Placebo 
New Medical 
Dictionary  1785  A common place method of medicine 
Hooper’s Medical 
Dictionary  1811  An epithet given to any medicine, adapted more to please 
than to benefit the patient. 
Dunglison; Dictionary 
of Medical Science  1874 
“I will please” (from placebo) – A medicine usually 
prescribed rather to satisfy the patient than with any 
expectation of its effecting a cure. 
Medical Lexicon  1881 
Name for a medicine given by a doctor to a patient simply to 
satisfy the patient’s mind; usually of a harmless nature, e.g. 
water colored with cochineal (dried insects used as dye). 
Standard Dictionary of 
the English Language  1895  Any harmless substance as bread pills, given to soothe a 
patient’s anxiety rather than as a remedy. Towards contemporary neuroethics: why does it make sense to re-define placebo? 
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Table 1. (Continuation from p.336) Some dictionary definitions of Placebo. 
Century Dictionary  1900  A medicine adapted rather to pacify than to benefit the patient. 
Chalmers Twentieth-
Century Dictionary  1911  A medicine given more to humor or gratify a patient than to 
exercise any curative effect. 
Pepper, O.H.P.  1948 
The giving of a placebo… seems to be a function of the 
physician which, like certain functions of the body, is not to 
be mentioned in polite society. 
Stedman’s Medical 
Dictionary  1953  An indifferent substance in the form of a medicine, given for 
the moral or suggestive effect. 
Oxford English 
Dictionary  1953  A medicine given to humor rather than to cure the patient. 
American Pocket 
Medical Dictionary  1953  An inert substance given as a medication. 
Britannica World 
Language  1960  Any harmless substance given to humor a patient or as a test 
in controlled experiments. Anything said to flatter or please. 
Webster’s 3rd New 
International 
Dictionary 
1971 
An inert medicament or preparation given for its 
psychological effect, esp. to satisfy a patient or act as a 
control in an experimental series. 
Taber’s medical 
Dictionary  1971 
1. Inactive substance given to satisfy patient’s demand for 
medicine. 2. Also used in the controlled studies of drugs. The 
placebo is given to a group of patients, and the drug being 
tested is given to a similar group; then the results obtained in 
the two groups are compared. Also, something tending to 
soothe or gratify. 
Brewer’s Dictionary 
of Phrase and Fable  1981  An innocuous medicine designed to humor a patient, and 
which may have a beneficial psychological and physical effect. 
Collins Dictionary of 
Medicine  1992 
1) A pharmacologically inactive substance made up in a 
form apparently identical to an active drug that is under trial. 
2) A harmless preparation prescribed to satisfy a patient who 
does not require active medication. 
Oxford Concise 
Medical Dictionary  1999 
A medicine that is ineffective but may help relieve a 
condition because a patient has faith in its powers. New 
drugs are tested against placebos in clinical trials: the drug 
effect compared with the placebo response, which occurs 
even in the absence of any pharmacologically active 
substance in the placebo. 
Dorland’s Medical 
Dictionary, 29th 
edition 
2001 
Any dummy medical treatment; originally a medical 
preparation having no specific pharmacological activity 
against the patient’s illness or complaint given solely for the 
psycho-physiological effects of the treatment. More recently, 
a dummy treatment administered to a control group in a 
controlled clinical trial in order that the specific and 
nonspecific effects of the experimental treatment can be 
distinguished – i.e. the experimental treatment must produce 
better results than the placebo in order to be considered 
effective. Active placebo, impure placebo: A substance 
having pharmacological properties that are not relevant to the 
condition being treated. 
 N. Gorjup and R. Gorjup 
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blind randomized clinical methodology appeared in the literature. To conclude, the 
metamorphosis of the term “Placebo” goes as follows: from the original definition placebo, 
which included not just medicines (substances) but also methods, later on the definitions of 
the term Placebo were limited only to medicines and further to inert substances. 
Finally, due to the new scientific research methodology, the definition of Placebo was 
revised. Today again, any method of the treatment is proposed to be added to the definition in 
order to provide a broader concept, which includes physiological as well as psychological 
treatments (i.e. active medication, surgical procedures and psychotherapy). 
Shapiro’s phenomenological definition 
“A placebo is any therapy (or that component of any therapy) that is intentionally or 
knowingly used for its nonspecific, psychological, or psycho-physiological, therapeutic 
effect, or that is used for a presumed specific therapeutic effect on a patient, symptom, or 
illness, but is without specific activity for the condition being treated. A placebo, when used 
as a control in experimental studies, is a substance or procedure that is without specific 
activity for the condition being treated” [25; p.41]. Oddly enough, how can something 
causing an effect be non-specific? 
CONTEMPORARY PLACEBO DEFINITIONS 
If men define situations as real, they are real in their consequences, is a well-known Thomas 
theorem that was formulated in 1928 as a fundamental Law of Sociology [29]. Curiously how 
authors with their theorem, perhaps unknowingly at that time were coming close to many of 
the modern definitions of placebo. The definitions proposed by some of the contemporary 
researchers such as Barrios, Benedetti, Di Blassi, Kirsh, Moreman and others agreed that 
perhaps the term “placebo effect” and “nonspecific effect” have some negative connotations 
and should be replaced by some more proper terms. Barrios points out that the placebo 
response is based on the power of belief or expectation [30]. Benedetti shows that the classic 
concepts of “placebo effect” are too restrictive, that we need a broader term, namely the 
“medical context”. He argues that the context effect (meaningful induced expectations) can 
help to explain the placebo effect through the doctor-patient interaction [31]. Di Blassi and 
colleagues proposed that we should use “placebo effect” interchangeably with the term 
“context effect” [32]. 
One of the leading authorities in the field of Placebo research Irving Kirsch, also the author 
of the Response expectancy theory [33] noted that when a person expects something to 
happen that is inconsistent with the common predicted pharmaco- dynamic properties of a 
drug, the effect of subject's expectations can prevail that of the medication. He defines 
response expectancies as anticipations for the occurrence of non-volitional responses and 
believes that they are the most important mediator in the placebo effect. Furthermore, 
according to his immediacy hypothesis [34] he suggests that an expectation for a subjective 
experience leads directly to that subjective experience (expectation of anxiety directly causes 
anxiety). In an interesting research design Kirsch and Wiexel elegantly showed how different 
is clinical setting from the research setting [35]. Moerman explains how meaning interacts 
with the illness and the healing process. He proposes the term “meaning response” as the 
physiological or psychological effect of meaning [14]. 
THE NEED FOR THE NEW PLACEBO DEFINITIONS 
So far, we recognized that there is no need any more for the use of the term placebo and 
placebo effect. Furthermore, there is no need even for using such terms as “nonspecific”, Towards contemporary neuroethics: why does it make sense to re-define placebo? 
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“inert” or “inactive”. Therefore, we propose new working definitions of Placebo, Placebo 
treatment, Placebo effect and Placebo response to replace the previous ones [26, 27]: 
 “Interpretation Potential” (IP) instead of “Placebo”, 
 “Interpretation Value” (IV) instead of “Placebo Treatment and/or Therapeutic Treatment”, 
 “Interpretation Effect” (IE) instead of “Therapeutic Effect” and/or “Placebo Effect” and 
 “Interpretation Response” (IR) instead of the term “Placebo Response/Treatment Response. 
According to our proposed definitions, contemporary Neuroethical standards should stand on 
the following three major premises [26, 27]: 
 Interpretation Potential (IP) in relation with the psychosocial context and its interpretation 
effects (IE) is a powerful healing determinant, having an effect in every treatment, 
 because of its “unpredictable” bidirectional nature and simultaneous interaction with the 
pharmaco-dynamic properties of a drug/treatment, this interpretation effect must be 
accompanied with the “Science of Compassionate Care” in every treatment, 
 Interpretation Response (IR) in the form of a well controled Interpretation Effect (IE) is 
more powerful and long lasting than Interpretation Value (IV) per se. 
DISCUSSION AND CONCLUSIONS 
Instead of thinking in dualities, such as body and mind, specific and nonspecific, active and 
inert, which were and still are the common concepts in defining the placebo and the placebo 
effects, we rather changed the working definitions in such a way that polarity was eliminated. 
Instead, we reorganized the terms into new concepts: interpretation potential (IP), 
interpretation value (IV), interpretation effect (IE), and interpretation response (IR). In this 
way, the importance was found to be crucial on the part of the doctor-patient relationship that 
distributed the healing power between the external factors and the internal locus of control 
through interpretation effects of individual understanding and meaning. In our opinion, the 
re-defined Placebo definitions as proposed above suggest that it seems wise to rethink of their 
possible impact on future directions in neuroethics. 
There is ample evidence supported by strong arguments claiming that it would be unethical to 
avoid Placebo effects [15]. Avoiding placebo effects means that we are avoiding real 
improvements of human well-being. Dorland’s Medical Dictionary from 2001 [28] 
demonstrates in Table 1 another conceptual inconsistency of traditional medical paradigm. 
While all drugs have to show they are better than placebo in order to be approved, there is 
one exception. Cancer drugs are never compared with placebo but instead these experimental 
drugs are always compared among themselves [36]. In oncology, placebo effect is regarded as 
unethical, but alleviating the negative psychological states with empathy and compassion could 
certainly help to reduce the immunosuppression thus helping patients to get well again [30]. It 
is now or never. Mind body interactions indicate no differences between pharmaco-dynamic 
and psychosocial effects, or to put another way cognitive affective events induced in a 
psychosocial context can trigger similar mechanisms as those activated by drugs [37]. If 
medical society will recognize the opportunity to define placebo as proposed above, then the 
art of a healing compassion can become a science - A science of compassionate care [26, 27]. 
By doing so the non-specific effect will become specific and the treatment will have the 
added effect. This effect is “gratis” and should be regarded in the future as psychosocial 
evidence based interpretation effect. By contrast, if medical society will insist on old 
definitions of Placebo in terms of duality then others will continue to manipulate and take 
advantage of the Placebo phenomenon. Let us here conclude with the last sentence from the 
book “The Powerful Placebo: from ancient Priest to modern Physician”: “If the non-specificity N. Gorjup and R. Gorjup 
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of the placebo effect can be rendered specific and its strength can be unleashed, the terms 
placebo and placebo effect can appropriately disappear into medical history.” [25; p.237]. 
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SAŽETAK 
Glavna poruka koju želimo prenijeti ovim člankom je da placebo nije inertni entitet nego sadrži potencijal 
subjektivne interpretacije, vlastiti potencijal zalječivanja, bitno različit od potencijala liječenja  per se. 
Zalječujući potencijal znatno ovisi o tome koliko jaku vrijednost interpretacije doktor stvori u liječenoj osobi. 
Pritom diskutiramo o postojanju mnoštva mogućnosti koje mogu utjecati na to koliko jaka vrijednost 
interpretacije može postati. Ključnu ulogu suvremene medicine vidimo u širenju uporabe učinaka interpretacije 
kao i u njihovom korištenju u smanjivanju bilo kojeg negativnog mentalnog stanja koje može nastaviti 
potiskivati djelovanje imuno-sustava nakon početnog zalječivanja. Drugim riječima, medicina bi trebala koristiti 
snagu učinaka interpretacije ne samo za privremeno nego i za trajno podizanje imuno-sustava. Za postizanje 
cjelokupnog procesa trajnog zalječivanja potrebno je iskoristiti prednosti uporabe vrijednosti interpretacije kroz 
psihosocijalni kontekst. To je moguće učiniti povrh uobičajene „pilule šećera“ pristupom temeljenim na dokazima 
– znanošću suosjećajne njege! Uvođenjem novih operativnih definicija placeba jasno pokazujemo kako je 
ljudski um (nesvjesni i svjesni) nezaobilazna cjelina u procesu zaliječivanja. Pojmovi „placebo“, „placebo 
učinak“ i „placebo odziv“ su redefinirani. Objašnjavamo kako više nema distinkcije (dualnosti) poput tijelo / 
um, specifično / nespecifično ili zdravlje / bolest što nudi nove uvide za budući razvoj suvremene neuroetike. 
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